Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam Monotherapy Conversion in Partial Onset Seizures
NCT00699283Phase 3Terminated
- Sponsor
- UCB
- Start
- Aug 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of brivaracetam in epilepsy, sponsored by UCB. Started Aug 2008; status: terminated.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00699283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699283.